**Core Concept**
The urea cycle is a critical metabolic pathway responsible for the detoxification of ammonia by converting it into urea, which is then excreted by the kidneys. The cycle involves the coordinated action of several enzymes, and defects in these enzymes can lead to hyperammonemia, a potentially life-threatening condition.

**Why the Correct Answer is Right**
The most common genetic enzyme defect in the urea cycle is Ornithine Transcarbamylase (OTC) deficiency. This enzyme catalyzes the transfer of a carbamoyl group from carbamoyl phosphate to ornithine, forming citrulline. Deficiency in OTC leads to a buildup of carbamoyl phosphate, which is then shunted towards the synthesis of pyrimidines, resulting in an imbalance of nucleotide pools. This can cause a range of clinical symptoms, including seizures, vomiting, and coma.

**Why Each Wrong Option is Incorrect**
**Option A:** Argininosuccinate synthetase (ASS) deficiency is another enzyme defect in the urea cycle, but it is less common than OTC deficiency.
**Option B:** Carbamoyl phosphate synthetase I (CPS I) deficiency is a rare enzyme defect in the urea cycle, primarily affecting the liver.
**Option C:** N-Acetylglutamate synthase (NAGS) deficiency is a rare enzyme defect in the urea cycle, primarily affecting the kidneys.

**Clinical Pearl / High-Yield Fact**
OTC deficiency is an X-linked recessive disorder, primarily affecting males. Females can be carriers, and in some cases, they may exhibit mild symptoms due to lyonization (X-chromosome inactivation).

**Correct Answer:** C. Carbamoyl phosphate synthetase I (CPS I) deficiency